Press

Smart NeuroScreen: IMC Krems Launches AI-Supported Research Project for the Digital Analysis of Neuronal Networks

New high-tech approach aims to accelerate drug development for neurodegenerative diseases

Under the leadership of Research Professor Christoph Wiesner, IMC Krems is launching the new research project “Smart NeuroScreen”. The project aims to establish an AI-supported, highly scalable screening platform for the precise analysis of neuronal cell models – an important step forward in drug discovery for diseases such as Alzheimer’s, Parkinson’s and ALS. The project is funded by the State of Lower Austria and co-financed by the European Union.

Christoph Wiesner, Research Professor at IMC Krems, is developing “Smart NeuroScreen”, an innovative platform for drug discovery in neurodegenerative diseases.